Unraveling brain fog in post-COVID syndrome: relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms

Delgado Alonso, Cristina, Díez Cirarda, María ORCID: https://orcid.org/0000-0001-6768-189X, Pagán Ortiz, Josué ORCID: https://orcid.org/0000-0002-8357-7950, Pérez Izquierdo, Carlos, Oliver Mas, Silvia ORCID: https://orcid.org/0009-0007-4188-6281, Fernández Romero, Lucía ORCID: https://orcid.org/0000-0003-0701-6227, Martínez Petit, Álvaro, Valles Salgado, María ORCID: https://orcid.org/0000-0001-6723-8265, Gil Moreno, María José ORCID: https://orcid.org/0000-0001-7474-7199, Yus, Miguel, Matías Guiu, Jorge ORCID: https://orcid.org/0000-0001-8162-9043, Ayala Rodrigo, José L. ORCID: https://orcid.org/0000-0001-7236-5330 and Matias Guiu, Jordi A. ORCID: https://orcid.org/0000-0001-5520-2708 (2023). Unraveling brain fog in post-COVID syndrome: relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. "European Journal of Neurology", v. 32 (n. 1); pp. 1-10. ISSN 1468-1331. https://doi.org/10.1111/ene.16084.

Descripción

Título: Unraveling brain fog in post-COVID syndrome: relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms
Autor/es:
Tipo de Documento: Artículo
Título de Revista/Publicación: European Journal of Neurology
Fecha: 5 Octubre 2023
ISSN: 1468-1331
Volumen: 32
Número: 1
Materias:
ODS:
Palabras Clave Informales: cognitive, COVID-19, depression, fatigue, long COVID
Escuela: E.T.S.I. Telecomunicación (UPM)
Departamento: Ingeniería Electrónica
Grupo Investigación UPM: Laboratorio de Sistemas Integrados LSI
Licencias Creative Commons: Reconocimiento - Sin obra derivada - No comercial

Texto completo

[thumbnail of 93732.pdf] PDF (Portable Document Format) - Se necesita un visor de ficheros PDF, como GSview, Xpdf o Adobe Acrobat Reader
Descargar (1MB)

Resumen

Background and purpose
“Brain fog” is a frequent and disabling symptom that can occur after SARS-CoV-2 infection. However, its clinical characteristics and the relationships among brain fog and objective cognitive function, fatigue, and neuropsychiatric symptoms (depression, anxiety) are still unclear. In this study, we aimed to examine the characteristics of brain fog and to understand how fatigue, cognitive performance, and neuropsychiatric symptoms and the mutual relationships among these variables influence subjective cognitive complaints.

Methods
A total of 170 patients with cognitive complaints in the context of post-COVID syndrome were evaluated using a comprehensive neuropsychological protocol. The FLEI scale was used to characterize subjective cognitive complaints. Correlation analysis, regression machine-learning algorithms, and mediation analysis were calculated.

Results
Cognitive complaints were mainly attention and episodic memory symptoms, while executive functions (planning) issues were less often reported. The FLEI scale, a mental ability questionnaire, showed high correlations with a fatigue scale and moderate correlations with the Stroop test, and anxiety and depressive symptoms. Random forest algorithms showed an R2 value of 0.409 for the prediction of FLEI score, with several cognitive tests, fatigue and depression being the best variables used in the prediction. Mediation analysis showed that fatigue was the main mediator between objective and subjective cognition, while the effect of depression was indirect and mediated through fatigue.

Conclusions
Brain fog associated with COVID-19 is mainly characterized by attention and episodic memory, and fatigue, which is the main mediator between objective and subjective cognition. Our findings contribute to understanding the pathophysiology of brain fog and emphasize the need to unravel the main mechanisms underlying brain fog, considering several aspects.

Proyectos asociados

Tipo
Código
Acrónimo
Responsable
Título
Comunidad de Madrid
G63-HEALTHSTARPLUS-HSP4
REACT-EU
Community of Madrid
Fundación para el Conocimiento Madri+d, Healthstart plus program
Gobierno de España
PID2019-110866RB-I00
Sin especificar
Sin especificar
Sin especificar
Gobierno de España
INT20/00079
Sin especificar
Instituto de Salud Carlos III
Sin especificar
Gobierno de España
CD22/00043
Sin especificar
Instituto de Salud Carlos III
Sin especificar
Gobierno de España
FI20/000145
Sin especificar
Instituto de Salud Carlos III
Sin especificar

Más información

ID de Registro: 93732
Identificador DC: https://oa.upm.es/93732/
Identificador OAI: oai:oa.upm.es:93732
URL Portal Científico: https://portalcientifico.upm.es/es/ipublic/item/10105963
Identificador DOI: 10.1111/ene.16084
URL Oficial: https://onlinelibrary.wiley.com/doi/10.1111/ene.16...
Depositado por: PhD Josué Pagán Ortiz
Depositado el: 08 Feb 2026 10:34
Ultima Modificación: 08 Feb 2026 10:34